Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical application.
about
Ginsenoside compound K suppresses the abnormal activation of T lymphocytes in mice with collagen-induced arthritis.A prebiotic fiber increases the formation and subsequent absorption of compound K following oral administration of ginseng in ratsEnhanced Absorption Study of Ginsenoside Compound K (20-O-β-(D-Glucopyranosyl)-20(S)-protopanaxadiol) after Oral Administration of Fermented Red Ginseng Extract (HYFRG™) in Healthy Korean Volunteers and Rats.Pharmacokinetics of ginsenoside Rb1 and its metabolite compound K after oral administration of Korean Red Ginseng extractGinsenosides and their metabolites: a review of their pharmacological activities in the skin.Selected ginsenosides of the protopanaxdiol series are novel positive allosteric modulators of P2X7 receptors.Food and Sex-Related Impacts on the Pharmacokinetics of a Single-Dose of Ginsenoside Compound K in Healthy Subjects.Determination of ginsenoside compound K in human plasma by liquid chromatography-tandem mass spectrometry of lithium adductsSingle- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers.
P2860
Q35146624-6F3AFC01-5C36-41B9-A228-D78922CEF7EBQ35675156-E140F1FC-FC0C-45C6-82B2-9EF3EC5F530DQ37144349-058F6729-3960-4AFF-BEC9-83628B3D7830Q37303203-9D1B54A9-5527-4DB5-A628-FBCA5CDC72F7Q38507618-D12C1A91-2527-4CC3-8FA1-982707F9E513Q38902193-7BAC9331-F96D-4ABD-8320-EF29B1E9EAFEQ41684414-B039AA79-9BBD-4AA4-9884-678DC5673E9CQ41952897-B3FBCCA1-4931-44F3-9D6B-EB34C91C1529Q49632028-3F401F16-6BB4-45FD-95A9-4D14E8B0536A
P2860
Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical application.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Development and validation of ...... asma and clinical application.
@en
type
label
Development and validation of ...... asma and clinical application.
@en
prefLabel
Development and validation of ...... asma and clinical application.
@en
P2093
P2860
P356
P1476
Development and validation of ...... asma and clinical application.
@en
P2093
Ji-Young Jeon
Jung Hyun Kim
Jung Soo Kim
Min-Gul Kim
Minho Hwang
Song-Hee Han
Soo-Wan Chae
Sun Young Lee
Yong-Jin Im
Yunjeong Kim
P2860
P304
P356
10.5142/JGR.2013.37.135
P577
2013-03-01T00:00:00Z